510(k) Report

510(k) · Cleared

Cleared

Optilite IgM CSF Kit

K190686510(k) TraditionalCleared May 28, 201971-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

The Binding Site Group, Ltd. · CFN Method, Nephelometric, Immunoglobulins (G, A, M)

Cleared on May 28, 2019 as substantially equivalent to K120750 (The Binding Site Group, Ltd., 2013) after a 71-day review. Its family tree reaches back 1 generation to 2013.

Decided
May 28, 2019
Review
71 days
Class
Class II
Product code
CFN
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K120750 (2013). No later device cites it as a predicate yet.

K120750 · Human Igm CSF Kit · The Binding Site Group, Ltd. · 2013201020122014201620182020
K120750 · Human Igm CSF Kit · The Binding Site Group, Ltd. · 20130
  1. Root · 1 generation backK120750 Human Igm CSF KitThe Binding Site Group, Ltd. · 2013
  2. This deviceK190686 Optilite IgM CSF KitThe Binding Site Group, Ltd. · 2019
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K120750Human Igm CSF KitThe Binding Site Group, Ltd.2013—
0 (this device)K190686Optilite IgM CSF KitThe Binding Site Group, Ltd.2019—
FIG. 1 — Lineage of K190686, 2013–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CFN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CFN device

  1. #1 K233663 N Antisera to Human Immunoglobulins (IgG, IgA…score 8.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K120750Human Igm CSF Kit
Summary page 5
…odium azide as a preservative. J. Substantial equivalence information: 1. Predicate device name(s) and 510(k) number(s): Human IgM CSF Kit for use on SPAPLUS K120750 Optilite IgM CSF Kit…
The Binding Site Group, Ltd.2013—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All CFN devices

CFN Method, Nephelometric, Immunoglobulins (G, A, M): FDA decisions, review times, recalls and adverse event reports over 20 years. 2019, this device’s year, is highlighted.

FDA decisions per year · CFN

2in 2023

2008: 72009: 42010: 22012: 12013: 42014: 22015: 12017: 12019: 62023: 2
2007high 7 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CFN

28in 2019

2008: 69 days median2009: 160 days median2013: 431 days median2019: 28 days median
2007high 431 (2013) · low 28 (2019)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · CFN

1in 2023

2014: 52018: 22022: 22023: 1
2007high 5 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CFN

1in 2024

2010: 32012: 32016: 22017: 42018: 22019: 82022: 12024: 1
2007high 8 (2019) · low 0 (2007)2025

MAUDE reports naming product code CFN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
200876900
2009416000
20102—03
20110—00
20121—03
2013443100
20142—50
20151—00
20160—02
20171—04
20180—22
201962808
20200—00
20210—00
20220—21
20232—10
20240—01
20250—00
20260—0—

What is it indicated for?

The Optilite IgM CSF Kit is intended for the quantitative in vitro measurement of I[gM in cerebrospinal fluid (CSF) samples using the Optilite analyser.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K190686: Optilite IgM CSF Kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K190686

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026